Search - tctmd.com

Displaying 1 - 16 of 16

Sort: Relevancy | Date

News Conference News ESC 2024

SHAM-PVI: Catheter Ablation Improves Objective Measure of AF Burden

Todd Neale

September 02, 2024

News Daily News

Sham Procedures in CV Research: What’s Sacrificed for Science?

Caitlin E. Cox

October 23, 2023

News Daily News

Top General Cardiology and Prevention News of 2022

Michael O'Riordan

December 26, 2022

News Conference News ESC 2022

Only Very Small Risk of Muscle Symptoms With Statins: CTT Collaboration

Michael O'Riordan

August 29, 2022

News Features

Novel Targets, Gene Edits, and Vaccines: Is a ‘Golden Era’ Dawning for ASCVD?

Michael O'Riordan

August 15, 2022

News Daily News

Good News and Bad for High-Intensity Statin Use in ASCVD

Michael O'Riordan

May 05, 2022

News Daily News

Statin Intolerance Overestimated—Only ‘Small Number’ Get Side Effects: Meta-analysis

Michael O'Riordan

February 18, 2022

News Conference News AHA 2021

An Oral PCSK9 Inhibitor? Early Data Show Safety, Big LDL Drops

Shelley Wood

November 15, 2021

News Daily News

Stopping Statins Ups CVD and Mortality Risks in Pill-Burdened Seniors

Michael O'Riordan

June 16, 2021

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2020

Shelley Wood

November 30, 2020

News Daily News

Subjective Statin-Related AEs Have Been Rising; Hard Proof, Not So Much

Michael O'Riordan

November 26, 2020

News Conference News AHA 2020

Both Statins and Placebos Produce ‘Very Real’ Side Effects: SAMSON

Michael O'Riordan

November 15, 2020

News Conference News EAS 2018

EAS Consensus Document Examines Safety of Statins Beyond Muscle Symptoms

Yael L. Maxwell

May 11, 2018

News Features

Trajectory Unknown: How ORBITA Lands in Clinical Practice Still Up for Debate

Michael O'Riordan

November 27, 2017

News Daily News

Statin-Intolerant Patients Have Significantly Worse Prognosis After MI

Michael O'Riordan

March 13, 2017

News Conference News ESC 2016

When Unblinded to Statin Therapy, Patients’ Muscle-Related Adverse Events Shoot Up: ASCOT Analysis

Michael O'Riordan

August 31, 2016

Advertisement

SHAM-PVI: Catheter Ablation Improves Objective Measure of AF Burden

Sham Procedures in CV Research: What’s Sacrificed for Science?

Top General Cardiology and Prevention News of 2022

Only Very Small Risk of Muscle Symptoms With Statins: CTT Collaboration

Novel Targets, Gene Edits, and Vaccines: Is a ‘Golden Era’ Dawning for ASCVD?

Good News and Bad for High-Intensity Statin Use in ASCVD

Statin Intolerance Overestimated—Only ‘Small Number’ Get Side Effects: Meta-analysis

An Oral PCSK9 Inhibitor? Early Data Show Safety, Big LDL Drops

Stopping Statins Ups CVD and Mortality Risks in Pill-Burdened Seniors

TCTMD’s Top 10 Most Popular Stories for November 2020

Subjective Statin-Related AEs Have Been Rising; Hard Proof, Not So Much

Both Statins and Placebos Produce ‘Very Real’ Side Effects: SAMSON

EAS Consensus Document Examines Safety of Statins Beyond Muscle Symptoms

Trajectory Unknown: How ORBITA Lands in Clinical Practice Still Up for Debate

Statin-Intolerant Patients Have Significantly Worse Prognosis After MI

When Unblinded to Statin Therapy, Patients’ Muscle-Related Adverse Events Shoot Up: ASCOT Analysis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content